News Categories
Resources For Living
Mesothelioma Forum
Legal Help Blog
Find a Doctor Near You
Mesothelioma Blog
Latest News
- Second-Hand Asbestos Exposure Responsible for Some Mesothelioma Cases
- Lab-on-Bead Offers Potential to Quickly Develop New Treatment for Mesothelioma
- “Rock for Doc” Concert Held to Raise Money for Doctor’s Mesothelioma Treatments
- NY Mesothelioma and Asbestos Attorney Applauds Changes to City’s Building Inspection Oversight
- Mesothelioma Patient Cancer-Free Five Years After Innovative Treatment
- University of Arizona’s Cancer Center Hopes to Become Premier Mesothelioma Treatment Facility in the Southwest
- SBRT, Useful for Treating Mesothelioma, to be Discussed at 2010 ASTRO Conference
- British Man Fights Mesothelioma by Running
- Ogdensburg Receives Grant Money to Demolish Buildings Known to Contain Mesothelioma-Causing Asbestos
- ADI-PEG 20 Shows Promise in Inhibiting Mesothelioma Cancer Cell Growth
Monday, October 22, 2007
Source: PubMed.com
Serum markers are an attempt to diagnose mesothelioma malignancies by analysis of a blood or other fluid test. This is a non-invasive procedure and discovering the efficacy of these diagnostic materials will be an important progression in our ability to diagnose mesothelioma. A study was recently completed that looked at the use of three different markers and their efficacy of diagnosis. It was found that Cyfra 21.1 was able to discriminate between healthy and malignant cells and that the combination of soluble mesothelin-related protein (SMRP) and carcino-embrionic antigen (CEA) was very effective for distinguishing between mesothelioma and non-small cell lung cancer.
Labels: mesothelioma
posted by Belluck & Fox at 1:57 PM
